EDAP to Present At 19th Annual Wall Street Analyst Forum

* Reuters is not responsible for the content in this press release.

Fri Sep 5, 2008 10:51am EDT 

LYON, France, Sept. 5, 2008 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the
global leader in therapeutic ultrasound, announced today that Marc Oczachowski,
Chief Executive Officer, and Eric Soyer, Chief Financial Officer, are scheduled
to present at the 19th Annual Wall Street Analyst Forum at the University Club
in New York City on Tuesday, September 9, 2008 at 12:30 p.m. ET.

A live web cast of the presentation will be available on EDAP's web site at
www.edap-tms.com. A replay of the web cast will be available for 30 days after
the date of the presentation.

About EDAP TMS SA

EDAP TMS SA develops and markets Ablatherm, the most advanced and clinically
proven choice for high-intensity focused ultrasound (HIFU) treatment of
localized prostate cancer. HIFU treatment is shown to be a minimally invasive
and effective treatment option with a low occurrence of side effects.
Ablatherm-HIFU is generally recommended for patients with localized prostate
cancer (stages T1-T2) who are not candidates for surgery or who prefer an
alternative option, or for patients who failed radiotherapy treatment. Approved
in Europe as a treatment for prostate cancer, Ablatherm-HIFU (High Intensity
Focused Ultrasound) is currently undergoing evaluation in a multicenter U.S.
Phase II/III clinical trial under an Investigational Device Exemption granted by
the FDA. The Company also is developing this technology for the potential
treatment of certain other types of tumors. EDAP TMS SA also produces and
commercializes medical equipment for treatment of urinary tract stones using
extra-corporeal shockwave lithotripsy (ESWL). For more information on the
company, please visit http://www.edap-tms.com, http://www.hifu-planet.com and
http://www.pcaresearch.com or http://www.urotoday.com/HIFU.

-0-
CONTACT:  EDAP TMS SA
          Investor Relations / Legal Affairs
          Blandine Confort
          +33 4 72 15 31 72
          bconfort@edap-tms.com

          The Ruth Group
          Investors:                       
          R.J. Pellegrino                  
          646-536-7009                   
          rpellegrino@theruthgroup.com
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.